Dr. Philip J. Boon Net Worth

The estimated Net Worth of Philip John Boon is at least $7.68 Million dollars as of 22 February 2024. Dr Boon owns over 3,715 units of Innospec Inc stock worth over $1,971,584 and over the last 15 years he sold IOSP stock worth over $4,278,126. In addition, he makes $1,429,527 as COO & Exec. VP at Innospec Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Dr Boon IOSP stock SEC Form 4 insiders trading

Dr has made over 27 trades of the Innospec Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 3,715 units of IOSP stock worth $453,490 on 22 February 2024.

The largest trade he's ever made was selling 30,000 units of Innospec Inc stock on 14 November 2019 worth over $2,886,300. On average, Dr trades about 3,432 units every 99 days since 2009. As of 22 February 2024 he still owns at least 18,516 units of Innospec Inc stock.

You can see the complete history of Dr Boon stock trades at the bottom of the page.

Dr. Philip J. Boon biography

Dr. Philip J. Boon is the COO & Exec. VP at Innospec Inc.

What is the salary of Dr Boon?

As the COO & Exec. VP of Innospec Inc, the total compensation of Dr Boon at Innospec Inc is $1,429,527. There are 2 executives at Innospec Inc getting paid more, with Patrick Williams having the highest compensation of $6,079,290.

How old is Dr Boon?

Dr Boon is 62, he's been the COO & Exec. VP of Innospec Inc since . There are 7 older and 14 younger executives at Innospec Inc. The oldest executive at Innospec Inc is Robert Paller, 85, who is the Independent Director.

What's Dr Boon's mailing address?

Philip's mailing address filed with the SEC is 8310 SOUTH VALLEY HIGHWAY, SUITE 350, ENGLEWOOD, CO, 80112.

Insiders trading at Innospec Inc

Over the last 19 years, insiders at Innospec Inc have traded over $58,440,000 worth of Innospec Inc stock and bought 623,592 units worth $12,018,765 . The most active insiders traders include Jeffrey L Et Al Gendell, Patrick Williams, and Jeffrey L Et Altontine Capi.... On average, Innospec Inc executives and independent directors trade stock every 21 days with the average trade being worth of $960,450. The most recent stock trade was executed by Ian Cleminson on 23 August 2024, trading 10,000 units of IOSP stock currently worth $1,139,900.

What does Innospec Inc do?

innospec is a global specialty chemicals company focused on bringing innovative new technologies to market combined with a fast and responsive service. we serve a range of industries across the world, bringing our products to customers in markets from oilfields, fuels, refineries and power stations to personal care. our global team of approximately 1300 employees spans 20 countries, applying their extensive experience and market understanding to customers’ local needs. integrating our global footprint with local service capability enables us to supply quality products that meet and anticipate changing market dynamics.

Complete history of Dr Boon stock trades at Innospec Inc

Innospec Inc executives and stock owners

Innospec Inc executives and other stock owners filed with the SEC include:

• Patrick Williams,
  President, Chief Executive Officer, Director
• Patrick S. Williams,
  Pres, CEO & Director
• Dr. Philip J. Boon,
  COO & Exec. VP
• Ian P. Cleminson,
  Exec. VP & CFO
• Philip Boon,
  Chief Operating Officer
• Ian Cleminson,
  Chief Financial Officer, Executive Vice President
• Ian McRobbie,
  Senior Vice President - Research and Technology
• Brian Watt,
  Senior Vice President - Corporate Development and Investor Relations
• Dr. Ian M. McRobbie,
  Chief Technology Officer and Sr. VP of Research & Technology
• Catherine Hessner,
  Senior Vice President - Human Resources
• Milton Blackmore,
  Non-Executive Chairman
• David Landless,
  Independent Director
• Joachim Roeser,
  Independent Director
• Lawrence Padfield,
  Independent Director
• Robert Paller,
  Independent Director
• Claudia Poccia,
  Director
• Elizabeth Arnold,
  Director
• David Jones,
  Chief Compliance Officer, Vice President, General Counsel, Corporate Secretary
• Graeme Blair,
  Principal Accounting Officer
• Steven W. Williams,
  Exec. Director
• Thomas C. Entwistle,
  Pres of Oilfield Services - Americas
• Dr. Catherine Hessner,
  Sr. VP of HR
• David Bentley Jones,
  VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec.
• Corbin Barnes,
  Sr. VP of Corp. Devel. & Investor Relations
• Graeme Blair,
  Head of Group Fin.
• Hugh Aldous,
  Director
• Martin Demora Hale,
  Director
• Larry Padfield,
  
• Philip Curran,
  Group Financial Controller
• Patrick Joseph Mcduff,
  EVP & PRESIDENT FS AMERICAS
• Paul Willis Jennings,
  Director
• Jeffrey L Et Al Gendell,
  10% owner
• Richard Tudor Shone,
  VP Safety, Health & Env.
• David Earl Williams,
  VP, General Counsel
• Jeffrey L Et Altontine Capi...,
  
• Jeffrey L Et Altontine Capi...,
  
• James Martin Combe Puckridge,
  Director
• Andrew Hartley,
  VP & General Counsel
• Jeffrey L Et Altontine Capi...,
  
• Peter Fearn,
  Director
• Mark Bracewell,
  
• Jeffrey L Et Altontine Capi...,
  
• Robert Ernest Bew,
  Director
• Charles M Hale,
  Director
• Simon Kirkpatrick Nuttall,
  
• William Martin Dawson,
  Exec VP Performance Chemicals
• Samuel Allen Haubold,
  Director
• Martin M Sr Hale,
  Director
• Leslie J Parrette,
  
• Corbin Barnes,
  SVP, Corporate Dev and IR
• Hardy Louis Iii Griffin,
  SVP, HUMAN RESOURCES